<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="32" ids="30145">Lithium</z:chebi> used in <z:e sem="disease" ids="C0005586" disease_type="Mental or Behavioral Dysfunction" abbrv="">bipolar mood disorder</z:e> therapy protects neurons from brain ischemic cell <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Here, we documented that <z:chebi fb="32" ids="30145">lithium</z:chebi> administration under microsphere-embolism (ME)-induced <z:e sem="disease" ids="C0007786" disease_type="Disease or Syndrome" abbrv="">brain ischemia</z:e> restored decreased protein kinase B (Akt) and Ca(2+)/calmodulin-dependent protein kinase II (CaMKII) activities 24 h after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> in rat brain </plain></SENT>
<SENT sid="2" pm="."><plain>Akt activation was associated with increased phosphorylation of its potential targets forkhead transcription factor (FKHR) and <z:chebi fb="15" ids="28087">glycogen</z:chebi> synthase kinase-3beta (GSK-3beta) </plain></SENT>
<SENT sid="3" pm="."><plain>In parallel with decreased CaMKII autophosphorylation, we also found marked dephosphorylation of tau proteins 24-72 h after ME </plain></SENT>
<SENT sid="4" pm="."><plain>Increased protein phosphatase 2A (PP2A) activity was found 24 h after ME </plain></SENT>
<SENT sid="5" pm="."><plain>Inhibition of increased PP2A activity by <z:chebi fb="32" ids="30145">lithium</z:chebi> treatment apparently mediated restored tau phosphorylation </plain></SENT>
<SENT sid="6" pm="."><plain>Taken together, activation of Akt and CaMKII by <z:chebi fb="32" ids="30145">lithium</z:chebi> was associated with neuroprotective activity in ME-induced neuronal injury </plain></SENT>
</text></document>